Corcept Therapeutics
CORT
#2313
Rank
$6.44 B
Marketcap
$61.53
Share price
1.43%
Change (1 day)
175.55%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of January 2025 (TTM): 10.3

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.1. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.15-59.54%๐Ÿ‡บ๐Ÿ‡ธ USA
2.52-75.38%๐Ÿ‡บ๐Ÿ‡ธ USA
4.14-59.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.7 72.54%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51-75.53%๐Ÿ‡บ๐Ÿ‡ธ USA
3.94-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA
1.26-87.71%๐Ÿ‡บ๐Ÿ‡ธ USA
6.31-38.52%๐Ÿ‡บ๐Ÿ‡ธ USA
4.39-57.16%๐Ÿ‡บ๐Ÿ‡ธ USA